Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma

Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma

Objective: Poorly differentiated thyroid carcinomas (PDTCs) are rare and aggressive head and neck malignancies with a poor prognosis. Systemic treatment for incurable PDTC consists of multi-kinase inhibitors (MKIs) based on extrapolation from the experience with radioiodine refractory differentiated...

Full description

Saved in:

Bibliographic Details
Main Authors:	Omar Elghawy, Adam Barsouk, Jessica Xu, Simon Chen, Roger B Cohen, Lova Sun
Format:	Article
Language:	English
Published:	Bioscientifica 2024-11-01
Series:	European Thyroid Journal
Subjects:	poorly differentiated thyroid cancer thyroid cancer cabozantinib lenvatinib sorafenib
Online Access:	https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0225.xml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib
by: Naoki Fukuda, et al.
Published: (2024-04-01)

Poorly differentiated thyroid cancer: Clinical, pathological, mutational, and outcome analysis
by: Amit Agarwal, et al.
Published: (2024-12-01)

Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series
by: Marilda Mormando, et al.
Published: (2024-12-01)

Cabozantinib Cutaneous Toxicity—Comprehensive Review
by: Cristina Violeta Tutunaru, et al.
Published: (2025-01-01)

Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study
by: Usman Khan, et al.
Published: (2020-11-01)

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
by: Jaekyung Cheon, et al.
Published: (2025-01-01)

Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab
by: Andrea S. Fung, et al.
Published: (2020-07-01)

Thermal ablation for the treatment of malignant thyroid nodules: present and future
by: Yan Hu, et al.
Published: (2024-12-01)

Efficacy and Safety of Pazopanib in the Treatment of Thyroid Cancer: A Systematic Review
by: Alexandra Laura Mederle, et al.
Published: (2024-12-01)

The influence of salt iodisation on the incidence of thyroid cancer
by: Karolina P. Sas, et al.
Published: (2024-09-01)

Radiofrequency Ablation for Recurrent Papillary Thyroid Carcinoma at the Central Compartment Node: A Case Report
by: Le Thi My, et al.

Development of animal models to study aggressive thyroid cancers
by: Shovan Dutta, et al.
Published: (2025-02-01)

Renal cell carcinoma metastasis to the thyroid gland: a case report
by: Andrii Hryshchyshyn, et al.
Published: (2024-12-01)

Thyroid cancer and Hashimoto's thyroiditis in AUS/FLUS nodules: is there a correlation? A retrospective study
by: Saad M. Alqahtani, MD, et al.
Published: (2024-12-01)

The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib
by: Shinichi Maruyama, et al.
Published: (2024-09-01)

Immune cells in thyroid adenoma and carcinoma: uncovering a hidden value of assessing tumor-host interplay and its potential application in thyroid cytopathology
by: Iryna Omelianenko, et al.
Published: (2025-01-01)

A pilot study examining Toronto-area family physician perspectives on thyroid neoplasm evaluation
by: Arjun Kundra, et al.
Published: (2019-05-01)

The predictive value of thyroid hormone sensitivity parameters for cervical lymph node metastasis in patients with differentiated thyroid cancer
by: Jingcheng Bi, et al.
Published: (2025-12-01)

Thyroid Mutations and Implications for Clinical Treatment
by: Emily S. Zhang, et al.
Published: (2024-12-01)

Hidden in Plain Sight: Incidental Diagnosis of Metastatic Papillary Thyroid Microcarcinoma Without Radiologically Apparent Thyroid Tumor
by: Natalie Rivera Vargas, MD, et al.
Published: (2025-01-01)

Diagnostic challenges in the assessment of thyroid neoplasms using nuclear features and vascular and capsular invasion: a multi-center interobserver agreement study
by: Agnes Stephanie Harahap, et al.
Published: (2024-11-01)

Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update
by: Yuejia Zhao, et al.
Published: (2025-02-01)

Cancer Risk in Thyroid Nodules: An Analysis of Over 1000 Consecutive FNA Biopsies Performed in a Single Canadian Institution
by: Elsabe J. Smit, et al.
Published: (2024-12-01)

A Rare Case of Metachronous Clear Cell Ovarian Carcinoma and Thyroid Carcinoma: Clinical and Pathological Insights
by: Ridwan S, et al.
Published: (2025-01-01)

Differences and analogies in thyroid cancer discovered incidentally or by thyroid-related screening: a multicenter study
by: Laura Croce, et al.
Published: (2025-02-01)

Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implications
by: Xiaoxiao Li, et al.
Published: (2024-12-01)

Aplastic anemia in a patient with papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis: a case report
by: Fei Wu, et al.
Published: (2025-01-01)

Thyroid concurrent papillary carcinoma and occult follicular carcinoma: Report of a rare case and discussion of surgical management strategies
by: Jingran Wang, et al.
Published: (2025-01-01)

Axillary Lymph Node Metastasis in Papillary Thyroid Carcinoma at Early Perioperative Period: Report of a Case and Review of the Literature
by: Cumhur Arıcı, et al.
Published: (2024-10-01)

Evaluation of the Her-2/neu value in papillary thyroid carcinoma and its relation to histopathological prognostic findings
by: Amin Azarnoosh, et al.
Published: (2024-01-01)

Case report: A case of lateral neck mass: ectopic thyroid carcinoma or lymph node metastasis?
by: Xinran Wei, et al.
Published: (2025-01-01)

Guest Editor: Raffaella Origa THYROID DISORDERS IN HOMOZYGOUS β-THALASSEMIA: CURRENT KNOWLEDGE, EMERGING ISSUES AND OPEN PROBLEMS
by: Vincenzo De Sanctis
Published: (2019-04-01)

Thyroid Hemiagenesis: An Incidental Discovery during Treatment for Papillary Thyroid Carcinoma
by: Chang Haur Lee, et al.
Published: (2024-11-01)

Re-visiting the ATA 2015 sonographic guidelines - who are we missing?: A retrospective review
by: D. S. Chan, et al.
Published: (2018-09-01)

Comparison of Preoperative Imaging and FNAB Results with Postoperative Pathology Results in Patients Undergoing AUS/FLUS
by: Ferhat Demir, et al.
Published: (2024-07-01)

A Real-Life Study in Patients Newly Diagnosed with Autoimmune Hashimoto’s Thyroiditis: Analysis of Asthenia as Admission Complaint
by: Ana Valea, et al.
Published: (2024-10-01)

Effects of Fibroblast Growth Factor 21 Serum Level on Clinicopathological Findings in Papillary Thyroid Carcinoma
by: Seyedarad Mosalamiaghili, et al.
Published: (2025-10-01)

Thyroid Dysfunction following Radiotherapy and Combined Therapy in Non-Thyroid Head and Neck Cancers
by: Rais Ahmad Bhat, et al.
Published: (2023-12-01)

Thyroid Hormones and Interference in Thyroid Function Tests: A Review
by: O. O. Edet, et al.
Published: (2024-11-01)

A Neglected Point: Frailty in Older Adults with Differentiated Thyroid Cancer
by: Meric Coskun, et al.
Published: (2024-12-01)